Small Good Things Positive news · Thoughtful choices

Health · Manchester, England, United Kingdom

Manchester hospital delivers UK's first NHS CAR-T therapy for aggressive blood cancer

Updated

The story in brief

What good news happened in Manchester, England, United Kingdom?

Manchester Royal Infirmary delivered the UK's first NHS treatment with obe-cel, a next-generation CAR-T immunotherapy, to a 28-year-old patient from Bury with acute lymphoblastic leukaemia on 2 January 2026. Manchester University NHS Foundation Trust reported that the global FELIX trial, in which the Manchester unit treated more patients than any other single centre, saw 77% of patients achieve remission after at least one infusion.

What is the background?

Acute lymphoblastic leukaemia (ALL) is an aggressive blood cancer that can progress quickly without effective treatment. CAR-T therapy NHS Manchester access marks a shift toward reprogramming a patient’s own immune cells to fight cancer, rather than relying solely on chemotherapy or a donor transplant.

What happened?

On 2 January 2026, Manchester Royal Infirmary gave a 28-year-old patient from Bury, diagnosed with acute lymphoblastic leukaemia in March 2025, the UK’s first NHS treatment with obe-cel. Obe-cel is a next-generation CAR-T immunotherapy that reprograms a patient’s own immune cells to recognise and destroy cancer cells more effectively than earlier treatments, delivered back to the patient in two separate doses.

Manchester Royal Infirmary treated more patients on the early-phase global FELIX trial than any other single centre — 24 of the 127 participants worldwide — giving the unit direct experience with the therapy ahead of this first NHS-funded use.

How did it happen?

Because Manchester’s unit treated the most FELIX trial patients of any single site, it was inspected by medical regulators from both the United States and Europe before obe-cel’s approval, according to Dr Eleni Tholouli, the trust’s consultant haematologist who led the treatment. That regulatory scrutiny, built on the unit’s trial experience, is part of what allowed Manchester to be first to deliver the treatment once it moved from trial to routine NHS care.

The FELIX trial results showed 77% of patients who received at least one obe-cel infusion achieved remission, with more durable remissions, improved survival rates, and significantly reduced toxicity compared with other immunotherapies.

Why does it matter?

Professor Peter Johnson, NHS National Clinical Director for Cancer, said: “The journey of obe-cel from scientific research in a UK university to a safe, effective, and affordable treatment… is a remarkable one.” A therapy that began as UK university research reaching NHS patients within the same national system shortens the usual gap between scientific discovery and patient access.

A 77% remission rate for an aggressive blood cancer, combined with reduced toxicity compared with earlier immunotherapies, means more patients can complete treatment with a realistic path to full remission rather than facing the harsher side effects of older CAR-T therapies.

What were the key results?

  • UK’s first NHS obe-cel treatment delivered 2 January 2026 at Manchester Royal Infirmary
  • Patient: 28-year-old from Bury, diagnosed with ALL in March 2025
  • Manchester treated 24 of 127 global FELIX trial participants — the most of any single centre
  • 77% of patients achieved remission after at least one obe-cel infusion in trials
  • Treatment showed improved survival rates and durability versus earlier immunotherapies
  • Significantly reduced toxicity compared with other CAR-T immunotherapies
  • Obe-cel originated from scientific research at a UK university before reaching NHS patients

What happens next?

Dr Tholouli said the unit can now offer real hope to Oscar and others in his situation.

Professor Peter Johnson is NHS National Clinical Director for Cancer. He said specialist NHS CAR-T centres deliver obe-cel and it will help more people like Oscar.

Sources & reporting notes

What changed

  1. Removed forward-looking statements in "What happens next?" that the cited sources did not support.
  1. Manchester University NHS Foundation Trust

    The published source for this story.

Have a correction or a confirmed update? Contact our editorial team.

Related reading

Elaine Roberts, in an #AndysManClub T-shirt, and Luke Ambler standing together outdoors.
Health Europe

More from United Kingdom

Andy's Man Club founders win Pride of Britain award

Elaine Roberts and Luke Ambler received a Special Recognition award at the 2026 Pride of Britain Awards. They set up Andy's Man Club after Elaine's son Andrew died by suicide in 2016. It began with nine men in Halifax and now runs more than 360 free peer-support groups, with about 7,000 men attending on Monday nights.

Read story
Asif Hasan, in a pale jacket, photographed outdoors.
Health Europe

More from United Kingdom

Asif Hasan wins Pride of Britain Lifetime Achievement award

Asif Hasan, head of paediatric cardiac surgery at Newcastle's Freeman Hospital for 30 years, won the Lifetime Achievement award at the 2026 Pride of Britain Awards. He estimates he performed around 400 transplants. He also helped develop ways to keep sick children alive until a donor heart is found.

Read story
Dr Eli Prior standing in a room decorated with bunting.
Health Europe

More from United Kingdom

Bedford train crash GP Eli Prior wins Pride of Britain award

Dr Eleanor 'Eli' Prior, a 41-year-old GP, received a Special Recognition award at the 2026 Pride of Britain Awards. She was badly hurt when her train crashed near Bedford in June. Despite a broken hand, she treated other passengers and then helped paramedics decide who needed care first.

Read story
Kirsty Waugh smiling in a garden, wearing a pink headband.
Health Europe

More from United Kingdom

Kirsty Waugh, 12, named Pride of Britain Child of Courage

Kirsty Waugh, 12, from Tunbridge Wells, won a Child of Courage award at the 2026 Pride of Britain Awards. While having chemotherapy for a brain tumour, she crocheted bunting that raised more than £120,000. Her 'My Name Is Kirsty' campaign has connected more than 14,000 Kirstys in over 50 countries and raised more than £125,000.

Read story